Evofem Biosciences

Company snapshot

Evofem Biosciences, Inc., (OTCID: EVFM) is a San-Diego based pharmaceutical company commercializing two FDA-approved sexual and reproductive health products. In 2020, we launched PHEXX® (lactic acid, citric acid, and potassium bitartrate), the first and only hormone-free, on-demand prescription contraceptive vaginal gel. In 2024, Evofem acquired and re-launched SOLOSEC® (secnidazole) 2 g oral gran

• 1 approved product(s) across US/EU regulatory metadata.
• 6 active pipeline program(s) linked via ClinicalTrials.gov.
• 8 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Evofem Biosciences. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Evofem Biosciences.

1. Jun 5, 2026 Clinical update

   LIPO-202 — Phase 3

2. May 23, 2026 Clinical update

   AMPHORA — Phase 3

3. May 23, 2026 Clinical update

   Conceptrol — Phase 3

4. May 23, 2026 Clinical update

   EVO100 — Phase 3

5. May 23, 2026 Clinical update

   EVO100 — Phase 3

View all clinical trial activity →

• What is Evofem Biosciences?

  Evofem Biosciences is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker EVFM. Primary therapeutic focus areas include Contraception, Chlamydia Trachomatis Infection, Sexually Transmitted Diseases, Central Abdominal Bulging. NovaPharmaNews links

• Is Evofem Biosciences publicly traded?

  Yes. Evofem Biosciences is listed with ticker EVFM on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Evofem Biosciences develop or market?

  We link 2 drug profile(s) where Evofem Biosciences is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/evofem-biosciences#company-drugs.

• What are the latest developments for Evofem Biosciences?

  In the last 12 months our linked public records show 6 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Evofem Biosciences focus on?

  Evofem Biosciences focuses on Contraception, Chlamydia Trachomatis Infection, Sexually Transmitted Diseases based on our analysis of their pipeline programs and drug development activities.